期刊文献+

降钙素原和常用炎症指标在脓毒症诊断及预后中的价值 被引量:21

The diagnostic value and prognostic significance of serum procalcitonin and Common inflammatory markers in patients with sepsis
原文传递
导出
摘要 目的探讨降钙素原(PCT)及常用炎症指标在脓毒症诊断及预后判断中的价值。方法采用回顾性病例对照研究。依据2001年SCCM/ESICM/ACCP/ATS/SIS国际脓毒症会议关于脓毒症诊断标准,将入选病例分为非感染性全身炎症反应综合征(SIRS)组,一般脓毒症组,严重脓毒症组,测定入院24 h内或临床怀疑脓毒症时血清PCT浓度及常用炎症指标并进行相关分析。结果 127例患者入选,其中非感染性SIRS组42例,一般脓毒症组47例,严重脓毒症组38例。一般脓毒症患者与非感染性SIRS患者相比,血清PCT[(1.82±1.57)μg/L vs.(0.63±0.65)μg/L,P<0.01],CRP[(84.87±64.58)mg/L vs.(51.31±59.02)mg/L,P<0.05]水平升高,严重脓毒症患者与一般脓毒症患者相比,血清PCT[(10.55±9.58)μg/L vs.(1.82±1.57)μg/L,P<0.01],CRP[(123.38±78.17)mg/L vs.(87±64.58)mg/L,P<0.05]明显升高?诊断脓毒症的ROC曲线下面积PCT 0.916±0.028,最佳截断值为0.885μg/ml,灵敏度91.8%、特异度81.0%,PCT与CRP联合诊断脓毒症的灵敏度达96.5%。预后良好组患者血清PCT水平明显低于预后不良组患者[(2.76±4.22)μg/L vs.(9.38±9.72)μg/L,P<0.01]。结论血清PCT是诊断脓毒症敏感度、特异度均较高的指标;PCT与CRP联合可提高诊断脓毒症的敏感性;PCT浓度的升高可反映脓毒症严重程度的增加;PCT的浓度越高,提示患者预后越差。 Objective To explore the diagnostic value and prognostic significance of serum procalcitonin and common inflammatory markers in patients with sepsis. Methods Patients were studied in a retrospective case-control method. According to the 2001 SCCM / ESICM / ACCP / ATS / SIS International Sepsis Definitions Conference,patients were divided into three groups: non-infectious SIRS group,sepsis group and severe sepsis group. Concentration of common inflammatory markers and PCT were determined at 24 hours or when sepsis was clinical suspected and their correlation was analyzed. Results 127 patients were enrolled,including 42 in non-infectious SIRS group,47 in sepsis group and 38 in severe sepsis group. The PCT and CRP levels of patients with sepsis and severe sepsis were significantly higher than that in non-infectious SIRS group[( 1. 82 ± 1. 57) vs.( 10. 55 ± 9. 58) vs.( 0. 63 ± 0. 65) μg/L,( 84. 87 ± 64. 58) vs.( 123. 38 ± 78. 17) vs.( 51. 31 ± 59. 02) mg/L,P〈0. 01 or P〈0. 05,respectively]. According to the receiver operating characteristic curves( ROC curves) analysis principle,ROC curves were drawn and areas under these curves( AUC) was calculated. In the diagnosis of sepsis,AUC values was 0. 916 ± 0. 028 for PCT,the best cutoff values was 0. 885 μg / L,sensitivity 91. 8%,specificity 81. 0%. The sensitivity of serum PCT joint CRP to diagnosis of sepsis was 96. 5%. The PCT levels of the patients with good prognosis were lower than those with poor prognosis[( 2. 76 ± 4. 22) vs.( 9. 38 ± 9. 72) μg / ml,P〈0. 01]. Conclusion Compared with commoninflammatory markers,serum PCT is a more sensitive and specific indicator in diagnosis of sepsis and to differentiate from non-infectious SIRS. PCT and CRP can increase the sensitivity of joint determination of sepsis. PCT can be used to reflect objectively the severity of sepsis and is helpful for prediction of prognosis in patients with sepsis.
出处 《中华肺部疾病杂志(电子版)》 CAS 2015年第4期4-8,共5页 Chinese Journal of Lung Diseases(Electronic Edition)
基金 2012年国家临床重点学科建设项目基金(卫医办政函2012 649号)
关键词 脓毒症 全身炎症反应综合征 降钙素原 C-反应蛋白 Sepsis Systemic inflammatory response syndrome Procalcitonin C-reactive protein
  • 相关文献

参考文献20

  • 1牛莎,张睢扬.脓毒症和脓毒症休克抗感染治疗进展[J].中华肺部疾病杂志(电子版),2013,6(3):1-3. 被引量:13
  • 2Jekarl DW, Lee SY, Lee J, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis [ J ]. Diagn Microbiol Infect Dis, 2013, 75(4): 342-347.
  • 3Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects [ J ]. J Clin Endocrinol Metab, 1994, 79 (6) : 1605-1608.
  • 4季娟娟,孙耕耘.降钙素原与呼吸道感染性疾病[J].中华肺部疾病杂志(电子版),2012,5(5):54-57. 被引量:16
  • 5Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference [ J ]. Crit Care Med, 2003, 31 (4) : 1250-1256.
  • 6Giamarellos-Bourboulis EJ, Tsangaris I, Kanni T, et al. Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study[J]. J Hosp Infect, 2011, 77(1): 58-63.
  • 7Murray CK, Hoffmaster RM, Schmit DR, et al. Evaluation of white blood cell Count, neutrophil percentage, and elevated temperature as predictors of bloodstream infection in burn patients [ Jl. Arch Surg, 2007, 142(7) :639-642.
  • 8Celik IH, Demirel FG, Uras N, et al. What are the cut-off levels for IL-6 and CRP in neonalal sepsis[J]. Clin Lab Anal, 2010, 24(6) : 407-412.
  • 9Maria FP, Jorge K, Daniel B, et al. C-reactive protein as a marker of mortality in intensive care unit [ J ]. Med Intensiva, 2008, 32 (9) : 424-430.
  • 10Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection [J]. Clin Infect Dis, 2011, 52 (4) : 346-350.

二级参考文献111

共引文献151

同被引文献160

  • 1陈玥,武抗美,金晔.血清降钙素追查甲状腺髓样癌一例临床报道[J].标记免疫分析与临床,2006,13(1):56-56. 被引量:2
  • 2无.儿童社区获得性肺炎管理指南(试行)(下)[J].中华儿科杂志,2007,45(3):223-230. 被引量:207
  • 3葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2013.259~265.
  • 4Briel M, Sehuetz P, MueHer B, et al.Proealcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care[J].Arch Intern Med, 2008, 168(14): 2000-2007.
  • 5Yusaf R, Whitlock P, Devereaux K, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, p!acebo-controlled~al[J]. Lancet, 2015,.386(!0):!243-1253.
  • 6Wilkins D, Wong P. Defining the systemic inflammatory response syndrome in equine neonates[J]. Vet Clin North Am Equine Pract, 2015, 31 (3):463-481.
  • 7Vastert V, Boom J, Anton P, et aL Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenileidiopathic arthritis[J]. Pediatr Rheumatol Online J, 2015, 13(1):55.
  • 8Guo Y, Tan Y, Tu D, et al. ST-elevation myocardial infarction following systemic inflammatory response syndrome[J]. Cardiovascular Journal of Africa, 2015, 26(3):1-3.
  • 9Dehpour H, Shafaroodi M, Hassanipottr Z, et al. The effects of sub- chronic treatment with pioglitazone on the septic mice mortali~ in the model of cecal ligation and puncture: involvement of nitric oxide pathway [J]. Acta Medica Iranica, 2015, 53(10):608-616.
  • 10NICKEL C H, BING|SSER R, MORGENTHALER N G. The role of copeptin as a diagnostic and prognostic biomarker for risk strati- fication in the emergency department[ J]. BMC Med, 2012, 10: 7.

引证文献21

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部